Clinical Trial Update: Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious Diarrhea [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the effects of crofelemer on the gut microbiome in healthy volunteers and HIV patients with non-infectious diarrhea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• Non-infectious Diarrhea

Drugs mentioned

• Crofelemer (crofelemer)

Snippet

Sponsor: Napo Pharmaceuticals, Inc. | Conditions: Acquired Immunodeficiency Syndrome, Healthy Volunteers | Phase 4 | Status: COMPLETED